(Q67923521)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

main subject

invasive aspergillosis

1 reference

J E Karp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

P A Burch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

W G Merz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

publication date

1 August 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

19 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

203-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic Use

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Favorable outcome of invasive aspergillosis in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Aspergillosis complicating neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Fungal infection in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

7 January 2021

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Invasive aspergillosis. Progress in early diagnosis and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Recognition and successful management in pulmonary aspergillosis in leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Antifungal susceptibility tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

Aspergillosis. The spectrum of the disease in 98 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980343-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(88)80343-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3165248%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference